(+)-Dihydromethysticin is a bioactive kavalactone isolated from the kava plant (Piper methysticum). It is notably recognized for its potent induction of the CYP3A23 enzyme, making it a relevant compound for research in drug metabolism, hepatotoxicity, and cytochrome P450 regulation in both in vitro and in vivo models.